[Skip to Content]
[Skip to Content Landing]
Article
October 1988

Failure of Antiviral Therapy for Acquired Immunodeficiency Syndrome-Related Cytomegalovirus Myelitis

Author Affiliations

From the Departments of Medicine (Drs Jacobson and Mills and Ms Rush), Ophthalmology (Dr O'Donnell), and Pathology (Neuropathology) (Drs Greco and Gonzales), University of California at San Francisco and San Francisco General Hospital, and the Department of Neurology, Children's Hospital, San Francisco (Dr Miller). Dr Gonzales is now with the Department of Anatomical Pathology, Royal Melbourne (Australia) Hospital.

Arch Neurol. 1988;45(10):1090-1092. doi:10.1001/archneur.1988.00520340044009
Abstract

• We report the first published case (to our knowledge) of histopathologically documented acquired immunodeficiency syndrome-related cytomegalovirus (CMV) myelitis in which antiviral drug therapy was administered. Despite sensitivity of the patient's CMV isolate to therapy with both ganciclovir and foscarnet, use of neither of these agents halted progression of central nervous system CMV disease. Higher doses of these drugs or combination therapy may be required to treat acquired immunodeficiency syndrome-related CMV myelitis effectively.

×